Sunday, March 31, 2019

Apexigen Announces New Clinical Data On APX005M In Combination Therapy For Pancreatic Cancer At The AACR Annual Meeting 2019

SAN CARLOS, Calif., March 31, 2019 /PRNewswire/ -- Apexigen, Inc., a clinical-stage biopharmaceutical company, today announced the presentation of new clinical data on APX005M in combination therapy in patients with metastatic pancreatic cancer. The data are being presented in a plenary...



from PR Newswire: https://ift.tt/2TOcevA

No comments:

Post a Comment